A phase II study testing a combination chemotherapy with epirubicin and vindesine as second line treatment for patients with advanced non-small cell lung cancer

Authors
Publication date
1 January 1995
Publisher

Abstract

SCOPUS: ar.jinfo:eu-repo/semantics/publishe

    Similar works

    Full text

    thumbnail-image

    Available Versions

    DI-fusion

    redirect
    oaioai:dipot.ulb.ac.be:2013/85600
    Last time updated on 25/07/2012